The global western blotting market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.7% during the forecast period. Technological advancements, increasing government funding in the field of biomedical research, growing demand for personalized medicine, and the rising prevalence of HIV are the key factors driving the market growth.

Request for Sample PDF Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=235810711

Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Techne Corporation (US), and Merck KGaA (Germany) are the prominent players operating in the western blotting market.

BIO-RAD LABORATORIES, INC. (US)

Bio-Rad Laboratories is a leading player in the western blotting market in 2020. The company is a leading manufacturer and supplier of products and systems to separate, detect, analyze, and purify complex biological and chemical materials. The company’s leading position in the market can be attributed to its wide customer base. Bio-Rad, with its ~8,000 employees (as of 2020), serves a wide and diversified customer base that includes universities and research institutes, supporting about 150,000 scientists in the US; companies operating in the pharmaceutical, biotechnology, chemical, and food industries; diagnostic manufacturers; and commercial laboratories and hospitals.

The company is also equipped with a strong distribution channel. Bio-Rad has established an extensive direct sales force and service network of approximately 740 sales and service representatives in more than 35 countries to conduct its worldwide operations efficiently. With its experienced industry experts, the company maintains a separate sales force for each of its segments. In addition, the company’s agents and distributors also assist in sales, especially in the international markets. The direct sales approach permits Bio-Rad to establish direct contact with its customers, thus helping the company to build strong relationships with customers.

THERMO FISHER SCIENTIFIC INC. (US)

Thermo Fisher Scientific held the second position in the western blotting market in 2020. The company provides a wide range of products in this market, including protein gels, protein standards & ladders, protein electrophoresis buffers & reagents, protein gel electrophoresis chamber systems, power supplies for protein electrophoresis, and protein gel staining and imaging products. These products are made available through Thermo Fisher Scientific’s broad sales force and global network of resellers and distributors. In recent years, organic strategies such as new product launches have enabled the company to maintain its position in the western blotting market.

For Instance, in June 2019, the company launched a new imaging series—Invitrogen iBright 1500. The iBright 1500 series is designed to support a broad set of applications. It can be used to image fluorescent western blots, chemiluminescent western blots, colorimetric blots, and stained protein and nucleic acid gels.